Tarsus Pharmaceuticals's total assets for Q2 2025 were $494.99M, a decrease of -1.15% from the previous quarter. TARS total liabilities were $162.38M for the fiscal quarter, a 2.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.